A. Schnabel

4.1k total citations
68 papers, 2.9k citations indexed

About

A. Schnabel is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Physiology. According to data from OpenAlex, A. Schnabel has authored 68 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pulmonary and Respiratory Medicine, 29 papers in Rheumatology and 19 papers in Physiology. Recurrent topics in A. Schnabel's work include Vasculitis and related conditions (30 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (18 papers) and Sarcoidosis and Beryllium Toxicity Research (16 papers). A. Schnabel is often cited by papers focused on Vasculitis and related conditions (30 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (18 papers) and Sarcoidosis and Beryllium Toxicity Research (16 papers). A. Schnabel collaborates with scholars based in Germany, Netherlands and China. A. Schnabel's co-authors include Wolfgang L. Gross, Wilfried Kindermann, H. Stegmann, Elena Csernok, Michael Reuter, Martin Heller, Bernhard Hellmich, E. Reinhold‐Keller, George P. Biro and M. Reuter and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, CHEST Journal and The American Journal of Medicine.

In The Last Decade

A. Schnabel

66 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Schnabel Germany 29 1.6k 995 892 431 418 68 2.9k
Alain Meyer France 29 356 0.2× 608 0.6× 336 0.4× 388 0.9× 1.0k 2.4× 160 2.9k
Samuel Katsuyuki Shinjo Brazil 23 377 0.2× 934 0.9× 199 0.2× 413 1.0× 1.0k 2.4× 231 2.5k
Sedat Kiraz Türkiye 32 889 0.6× 1.2k 1.2× 150 0.2× 719 1.7× 340 0.8× 195 3.9k
B Mazières France 27 212 0.1× 1.6k 1.6× 142 0.2× 189 0.4× 203 0.5× 145 3.0k
Roberta Priori Italy 37 263 0.2× 1.3k 1.3× 1.4k 1.6× 885 2.1× 300 0.7× 158 3.9k
Theodoros Dimitroulas Greece 28 584 0.4× 971 1.0× 330 0.4× 413 1.0× 313 0.7× 173 2.6k
Michael O. Harris‐Love United States 23 105 0.1× 506 0.5× 787 0.9× 233 0.5× 1.1k 2.6× 56 2.8k
Itzhak Rosner Israel 31 293 0.2× 839 0.8× 165 0.2× 620 1.4× 416 1.0× 135 2.7k
Chester V. Oddis United States 45 1.5k 1.0× 3.6k 3.6× 373 0.4× 1.4k 3.2× 5.5k 13.2× 150 7.6k
Kristian Stengaard‐Pedersen Denmark 32 133 0.1× 1.2k 1.2× 197 0.2× 1.1k 2.4× 259 0.6× 119 3.4k

Countries citing papers authored by A. Schnabel

Since Specialization
Citations

This map shows the geographic impact of A. Schnabel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Schnabel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Schnabel more than expected).

Fields of papers citing papers by A. Schnabel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Schnabel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Schnabel. The network helps show where A. Schnabel may publish in the future.

Co-authorship network of co-authors of A. Schnabel

This figure shows the co-authorship network connecting the top 25 collaborators of A. Schnabel. A scholar is included among the top collaborators of A. Schnabel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Schnabel. A. Schnabel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schnabel, A.. (2013). Interstitielle Lungenkrankheit bei Polymyositis/Dermatomyositis. Zeitschrift für Rheumatologie. 72(3). 220–226. 2 indexed citations
2.
Schnabel, A. & M. Reuter. (2009). Interstitielle Lungenkrankheit bei Kollagenosen. Zeitschrift für Rheumatologie. 68(8). 650–657. 1 indexed citations
3.
Richter, Clemens, A. Schnabel, K.-M. Müller, et al.. (2008). Lymphomatoide Granulomatose - Remissionsinduktion mit lnterferon-α2b. DMW - Deutsche Medizinische Wochenschrift. 122(37). 1106–1110. 4 indexed citations
4.
5.
Schäfer, Ulrich, et al.. (2002). Drug-Induced Lupus Erythematosus by Amiodarone. Archives of Internal Medicine. 162(7). 834–834. 34 indexed citations
6.
Hellmich, Bernhard, Elena Csernok, Masja de Haas, et al.. (2002). Low Fcγ receptor III and high granulocyte colony-stimulating factor serum levels correlate with the risk of infection in neutropenia due to Felty’s syndrome or systemic lupus erythematosus. The American Journal of Medicine. 113(2). 134–139. 18 indexed citations
7.
Hellmich, Bernhard, Elena Csernok, Helmut Schatz, Wolfgang L. Gross, & A. Schnabel. (2002). Autoantibodies against granulocyte colony‐stimulating factor in Felty's syndrome and neutropenic systemic lupus erythematosus. Arthritis & Rheumatism. 46(9). 2384–2391. 71 indexed citations
8.
Lamprecht, Peter, Elena Csernok, Antje Mueller, et al.. (2002). Peripheral Blood and Granuloma CD4+CD28− T Cells Are a Major Source of Interferon-γ and Tumor Necrosis Factor-α in Wegener’s Granulomatosis. American Journal Of Pathology. 160(5). 1717–1724. 163 indexed citations
9.
Lamprecht, Peter, Gabór Kumánovics, Antje Mueller, et al.. (2002). Elevated monocytic IL-12 and TNF-αproduction in Wegener's granulomatosis is normalized by cyclophosphamide and corticosteroid therapy. Clinical & Experimental Immunology. 128(1). 181–186. 29 indexed citations
10.
Muraközy, G., Karoline I. Gaede, Ola Gutzeit, et al.. (2001). Gene polymorphisms of immunoregulatory cytokines and angiotensin-converting enzyme in Wegener's granulomatosis. Journal of Molecular Medicine. 79(11). 665–670. 40 indexed citations
11.
Schnabel, A., Elena Csernok, Jörg Braun, & Wolfgang L. Gross. (2000). Activation of Neutrophils, Eosinophils, and Lymphocytes in the Lower Respiratory Tract in Wegener's Granulomatosis. American Journal of Respiratory and Critical Care Medicine. 161(2). 399–405. 25 indexed citations
12.
Schnabel, A., Harald Renz, Rachel Petermann, Elena Csernok, & Wolfgang L. Gross. (1999). T Cell Receptor Vβ Repertoire in Bronchoalveolar Lavage in Wegener’s Granulomatosis and Sarcoidosis. International Archives of Allergy and Immunology. 119(3). 223–230. 4 indexed citations
13.
Tatsis, Efstratios, et al.. (1999). Glomerular and tubular proteinuria as markers of nephropathy in rheumatoid arthritis. Lara D. Veeken. 38(1). 28–33. 21 indexed citations
14.
Hellmich, Bernhard, A. Schnabel, & Wolfgang L. Gross. (1999). Granulocyte colony-stimulating factor treatment for cyclophosphamide-induced severe neutropenia in Wegener's granulomatosis. Arthritis & Rheumatism. 42(8). 1752–1756. 16 indexed citations
15.
Schnabel, A., et al.. (1999). Bronchoalveolar lavage cell profiles in Wegener's granulomatosis. Respiratory Medicine. 93(7). 498–506. 19 indexed citations
16.
Hellmich, Bernhard, A. Schnabel, & Wolfgang L. Gross. (1999). Treatment of severe neutropenia due to Felty's syndromeor systemic lupus erythematosus with granulocyte colony-stimulating factor. Seminars in Arthritis and Rheumatism. 29(2). 82–99. 32 indexed citations
17.
Schnabel, A., Michael Reuter, & Wolfgang L. Gross. (1998). Intravenous pulse cyclophosphamide in the treatment of interstitial lung disease due to collagen vascular diseases. Arthritis & Rheumatism. 41(7). 1215–1220. 105 indexed citations
18.
Schnabel, A., et al.. (1996). Sustained cough in methotrexate therapy for rheumatoid arthritis. Clinical Rheumatology. 15(3). 277–282. 19 indexed citations
19.
Schnabel, A., Elena Csernok, David Isenberg, Christian Mrowka, & Wolfgang L. Gross. (1995). Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Arthritis & Rheumatism. 38(5). 633–637. 98 indexed citations
20.
Schnabel, A., et al.. (1993). Treatment of Wegener’s Granulomatosis with Intravenous Immunoglobulin. Advances in experimental medicine and biology. 336. 487–489. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alain Meyer Breakdown of academic impact, for papers by Samuel Katsuyuki Shinjo Breakdown of academic impact, for papers by Sedat Kiraz Breakdown of academic impact, for papers by B Mazières Breakdown of academic impact, for papers by Roberta Priori Breakdown of academic impact, for papers by Theodoros Dimitroulas Breakdown of academic impact, for papers by Michael O. Harris‐Love Breakdown of academic impact, for papers by Itzhak Rosner Breakdown of academic impact, for papers by Chester V. Oddis Breakdown of academic impact, for papers by Kristian Stengaard‐Pedersen
Rankless by CCL
2026